REGENXBIO Inc..
RGNX.US | Research and experimental development on natural sciences and engineering
REGENXBIO Inc. is a clinical-stage biotechnology company focused on the development, commercialization, and licensing of adeno-associated virus (AAV) gene therapies. The company's gene therapy product candidates are designed to deliver functional genes to cells to address genetic defects or acquired...Show More
Better Health for All
0
No evidence available to assess REGENXBIO Inc. on Better Health for All.
Fair Money & Economic Opportunity
0
REGENXBIO Inc. is a clinical-stage biotechnology company focused on gene therapies, not a financial institution.
1
The company's core business does not involve lending, insuring, moving, or storing money for consumers or communities.
2
Therefore, all KPIs related to 'Fair Money & Economic Opportunity' are not applicable, as they pertain to financial services and their impact on economic opportunity and inclusion.
Fair Pay & Worker Respect
30
REGENXBIO Inc. reported a CEO to median employee pay ratio of 15:1 for the 2024 fiscal year.
1
The CEO's pay was $3,495,826, while the median employee pay was $226,641.
2
The company's Rockville, MD headquarters is LEED Gold certified.
3
Fair Trade & Ethical Sourcing
0
No evidence available to assess REGENXBIO Inc. on Fair Trade & Ethical Sourcing.
Honest & Fair Business
0
No specific, concrete data points were found in the provided articles to assess REGENXBIO Inc. against the defined KPIs for the 'Honest & Fair Business' ethical value. Therefore, no KPIs can be scored.
Kind to Animals
-40
REGENXBIO Inc. conducts animal testing for its medical products and therapies, including preclinical trials and animal models, as required for biological product development and FDA approval.
1
The company states that these animal studies are conducted in accordance with Good Laboratory Practice (GLP) and applicable requirements for the humane use of laboratory animals, including compliance with the Animal Welfare Act.
2
While in vitro testing is mentioned in the context of safety risk assessment,
3
the extent to which non-animal testing methods are employed for product safety and efficacy is not specified, and animal assays appear to dominate the development process.
4
No War, No Weapons
0
REGENXBIO Inc. is a clinical-stage biotechnology company focused on gene therapies. The provided articles explicitly state that the company's business activities are not applicable to defense or arms contracts, nor do they contain data relevant to 'No War, No Weapons' metrics. Specifically, notes that the company is 'not a defense contractor,' and confirms that it 'does not contain any data relevant to the requested metrics for RGNX.US related to arms or defense contracts, peacebuilding, or conflict-related issues.'
1
This indicates that the company's core business does not involve defense or arms-related activities, dual-use technologies, sales to embargoed regimes, or other conflict-related operations.
Planet-Friendly Business
0
No specific, concrete data points were found in the provided articles for any of the Planet-Friendly Business KPIs.
1
Information regarding environmental performance, targets, or initiatives is not available.
2
Respect for Cultures & Communities
0
No specific, concrete data points were found in the provided articles that directly address the KPIs related to 'Respect for Cultures & Communities'. The articles primarily focus on financial performance, clinical trial updates, commercial partnerships, and internal workforce diversity (gender and historically underrepresented minority populations), rather than community engagement, cultural preservation, or local community investment.
Safe & Smart Tech
0
No evidence available to assess REGENXBIO Inc. on Safe & Smart Tech.
Zero Waste & Sustainable Products
-40
The company engages in multiple initiatives to improve manufacturing yields and is measuring waste generation and emissions to identify reduction opportunities.
1
It has also been locally recognized for its waste reduction and recycling programs.
2
The company uses, handles, and disposes of various biological, chemical, and radioactive substances, stating it believes it is in material compliance with applicable environmental laws.
3
Its Rockville, Maryland headquarters is Leadership in Energy and Environmental Design Gold certified, and its Manufacturing Innovation Center is designed to achieve LEED Silver certification.
4